NM_012105.5:c.1135-1116G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_012105.5(BACE2):c.1135-1116G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.274 in 151,608 control chromosomes in the GnomAD database, including 6,909 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.27 ( 6909 hom., cov: 32)
Consequence
BACE2
NM_012105.5 intron
NM_012105.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.539
Publications
4 publications found
Genes affected
BACE2 (HGNC:934): (beta-secretase 2) This gene encodes an integral membrane glycoprotein that functions as an aspartic protease. The encoded protein cleaves amyloid precursor protein into amyloid beta peptide, which is a critical step in the etiology of Alzheimer's disease and Down syndrome. The protein precursor is further processed into an active mature peptide. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.469 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BACE2 | NM_012105.5 | c.1135-1116G>A | intron_variant | Intron 7 of 8 | ENST00000330333.11 | NP_036237.2 | ||
| BACE2 | NM_138991.3 | c.985-1116G>A | intron_variant | Intron 6 of 7 | NP_620476.1 | |||
| BACE2 | NM_138992.3 | c.1134+5141G>A | intron_variant | Intron 7 of 7 | NP_620477.1 | |||
| BACE2 | XM_017028314.2 | c.850-1116G>A | intron_variant | Intron 8 of 9 | XP_016883803.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.273 AC: 41391AN: 151492Hom.: 6881 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
41391
AN:
151492
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.274 AC: 41486AN: 151608Hom.: 6909 Cov.: 32 AF XY: 0.271 AC XY: 20093AN XY: 74064 show subpopulations
GnomAD4 genome
AF:
AC:
41486
AN:
151608
Hom.:
Cov.:
32
AF XY:
AC XY:
20093
AN XY:
74064
show subpopulations
African (AFR)
AF:
AC:
19609
AN:
41306
American (AMR)
AF:
AC:
3666
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
AC:
758
AN:
3464
East Asian (EAS)
AF:
AC:
780
AN:
5170
South Asian (SAS)
AF:
AC:
1234
AN:
4786
European-Finnish (FIN)
AF:
AC:
1498
AN:
10410
Middle Eastern (MID)
AF:
AC:
73
AN:
292
European-Non Finnish (NFE)
AF:
AC:
13210
AN:
67928
Other (OTH)
AF:
AC:
540
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1385
2770
4156
5541
6926
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
874
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.